Günter Emons

11.2k total citations
248 papers, 7.0k citations indexed

About

Günter Emons is a scholar working on Reproductive Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Günter Emons has authored 248 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Reproductive Medicine, 86 papers in Genetics and 49 papers in Molecular Biology. Recurrent topics in Günter Emons's work include Estrogen and related hormone effects (78 papers), Ovarian cancer diagnosis and treatment (61 papers) and Endometrial and Cervical Cancer Treatments (43 papers). Günter Emons is often cited by papers focused on Estrogen and related hormone effects (78 papers), Ovarian cancer diagnosis and treatment (61 papers) and Endometrial and Cervical Cancer Treatments (43 papers). Günter Emons collaborates with scholars based in Germany, United States and Switzerland. Günter Emons's co-authors include Carsten Gründker, Olaf Ortmann, Andrew V. Schally, Andreas R. Günthert, R. Knüppen, Rainer Girgert, Volker Viereck, Peter Völker, Lorenz C. Hofbauer and Sabine Blaschke and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Günter Emons

225 papers receiving 6.8k citations

Peers

Countries citing papers authored by Günter Emons

Since Specialization

Citations

This map shows the geographic impact of Günter Emons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günter Emons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günter Emons more than expected).

Fields of papers citing papers by Günter Emons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günter Emons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günter Emons. The network helps show where Günter Emons may publish in the future.

Co-authorship network of co-authors of Günter Emons

This figure shows the co-authorship network connecting the top 25 collaborators of Günter Emons. A scholar is included among the top collaborators of Günter Emons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günter Emons. Günter Emons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells 2020 ·Cells ·(unknown), (unknown), (unknown), Florian Wegwitz, Gerd Bauerschmitz, Günter Emons, Carsten Gründker	7
2	New WHO Classification of Endometrial Hyperplasias 2015 ·Geburtshilfe und Frauenheilkunde ·Günter Emons, Matthias W. Beckmann, D Schmidt, Peter Mallmann, (unknown)	109
3	Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol 2014 ·BMC Cancer ·Rainer Girgert, Günter Emons, Carsten Gründker	29
4	Recommendations for the Diagnosis and Treatment of Endometrial Cancer, Update 2013 2014 ·Geburtshilfe und Frauenheilkunde ·Günter Emons, Peter Mallmann, (unknown)	1
5	Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo 2011 ·Breast Cancer Research and Treatment ·Antje Schubert, Thomas Hawighorst, Günter Emons, Carsten Gründker	25
6	Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families 2011 ·Familial Cancer ·(unknown), Albert Rosenberger, Uwe Engel, (unknown), Günter Emons, Moneef Shoukier	9
7	Dauertokolyse mit β₂-Sympathikomimetika – Retrospektive Analyse an einem Zentrum 2009 ·Zeitschrift für Geburtshilfe und Neonatologie ·W Stein, (unknown), (unknown), Günter Emons	3
8	Membrane‐bound melatonin receptor MT1 down‐regulates estrogen responsive genes in breast cancer cells 2009 ·Journal of Pineal Research ·Rainer Girgert, Volker Hanf, Günter Emons, Carsten Gründker	56
9	Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma 2009 ·Journal of Cancer Research and Clinical Oncology ·Günter Emons, Rainer Kimmig	12
10	GnRH analogs reduce invasiveness of human breast cancer cells 2006 ·Breast Cancer Research and Treatment ·Julia Alten, (unknown), (unknown), Volker Viereck, Karl‐Heinz Frosch, Günter Emons, Carsten Gründker	35
11	Anthracycline and trastuzumab in breast cancer treatment. 2004 ·PubMed ·Michael Untch, (unknown), Steffen Kahlert, (unknown), Holger Eidtmann, Andreas du Bois, H.G. Meerpohl, Christoph Thomssen, Nadia Harbeck, C Jackisch, R. Kreienberg, Günter Emons, D. Wallwiener, William H. Wiese, Gerhard Schäller, W. Kühn, M Muscholl, M. Pauschinger, Bernd Langer	6
12	Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells. 2004 ·PubMed ·Andreas R. Günthert, Carsten Gründker, Bettina Böttcher, Günter Emons	16
13	Konsensusempfehlungen zur Hormontherapie (HT) im Klimakterium und in der Postmenopause - im Auftrag des Vorstands der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe 2003 ·Geburtshilfe und Frauenheilkunde ·Olaf Ortmann, (unknown), W. Braendle, Cosima Brucker, Martina Dören, Günter Emons, F. Geisthövel, Ludwig Kiesel, (unknown), (unknown), T. Rabe, E. Windler	4
14	Factor XII deficiency is strongly associated with primary recurrent abortions 2003 ·Fertility and Sterility ·Hans‐Ulrich Pauer, Peter Burfeind, H. Köstering, Günter Emons, B. Hinney	43
15	Introitussonographie des unteren Genitaltraktes vor und nach Kolposuspension: eine sechsmonatige Nachbeobachtung 2003 ·Ultraschall in der Medizin - European Journal of Ultrasound ·Volker Viereck, Hans‐Ulrich Pauer, Werner Bader, Rainer Lange, (unknown), Günter Emons, Reinhard Hilgers, (unknown), Thomas F. Krauss	6
16	Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer 2002 ·Annals of Oncology ·Andreas du Bois, Werner Meier, Hans‐Joachim Lück, Günter Emons, Volker Moebus, W. Schroeder, Serban Dan Costa, Thomas Bauknecht, S. Olbricht, Christian Jackisch, Barbara Richter, Uwe Wagner	41
17	Expression of Gonadotropin-Releasing Hormone II (GnRH-II) Receptor in Human Endometrial and Ovarian Cancer Cells and Effects of GnRH-II on Tumor Cell Proliferation 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Carsten Gründker, Andreas R. Günthert, Robert P. Millar, Günter Emons	134
18	Hormonsubstitution und Endometriumkarzinom 2001 ·Journal für Kardiologie (Krause & Pachernegg GmbH) ·Günter Emons	2
19	Modulatory action of progesterone and progesterone antagonists on hypothalamic-pituitary function 1994 ·Human Reproduction ·Olaf Ortmann, Kevin Catt, K.-D. Schulz, Günter Emons	4
20	Hormone replacement therapy and endometrial cancer. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Günter Emons, (unknown), (unknown), B. Hinney	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact